Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Snapshot
The global Opioid Induced Constipation Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Opioid Induced Constipation Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Opioid Induced Constipation Drugs Industry
Figure Opioid Induced Constipation Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Opioid Induced Constipation Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Opioid Induced Constipation Drugs
1.2.2 Downstream
Table Application Segment of Opioid Induced Constipation Drugs
Table Global Opioid Induced Constipation Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Opioid Induced Constipation Drugs Market by Type
3.1 By Type
3.1.1 Lubiprostone
Table Major Company List of Lubiprostone
3.1.2 Methyl Naltrexone Bromide
Table Major Company List of Methyl Naltrexone Bromide
3.1.3 Naldemedine
Table Major Company List of Naldemedine
3.1.4 Alvimopan
Table Major Company List of Alvimopan
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Opioid Induced Constipation Drugs Market 2016-2020, by Type, in USD Million
Figure Global Opioid Induced Constipation Drugs Market Growth 2016-2020, by Type, in USD Million
3.3 Market Forecast
Table Global Opioid Induced Constipation Drugs Market Forecast 2021-2026, by Type, in USD Million
4 Major Companies List
4.1 Ironwood Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.1.1 Ironwood Pharmaceuticals Inc Profile
Table Ironwood Pharmaceuticals Inc Overview List
4.1.2 Ironwood Pharmaceuticals Inc Products & Services
4.1.3 Ironwood Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Daiichi Sankyo Co Ltd (Company Profile, Sales Data etc.)
4.2.1 Daiichi Sankyo Co Ltd Profile
Table Daiichi Sankyo Co Ltd Overview List
4.2.2 Daiichi Sankyo Co Ltd Products & Services
4.2.3 Daiichi Sankyo Co Ltd Business Operation Conditions
Table Business Operation of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer (Company Profile, Sales Data etc.)
4.3.1 Pfizer Profile
Table Pfizer Overview List
4.3.2 Pfizer Products & Services
4.3.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Progenics Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.4.1 Progenics Pharmaceuticals Inc Profile
Table Progenics Pharmaceuticals Inc Overview List
4.4.2 Progenics Pharmaceuticals Inc Products & Services
4.4.3 Progenics Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Shionogi & Co., Ltd (Company Profile, Sales Data etc.)
4.5.1 Shionogi & Co., Ltd Profile
Table Shionogi & Co., Ltd Overview List
4.5.2 Shionogi & Co., Ltd Products & Services
4.5.3 Shionogi & Co., Ltd Business Operation Conditions
Table Business Operation of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Allergan Plc (Company Profile, Sales Data etc.)
4.6.1 Allergan Plc Profile
Table Allergan Plc Overview List
4.6.2 Allergan Plc Products & Services
4.6.3 Allergan Plc Business Operation Conditions
Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Nektar Therapeutics (Company Profile, Sales Data etc.)
4.7.1 Nektar Therapeutics Profile
Table Nektar Therapeutics Overview List
4.7.2 Nektar Therapeutics Products & Services
4.7.3 Nektar Therapeutics Business Operation Conditions
Table Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Purdue Pharma (Company Profile, Sales Data etc.)
4.8.1 Purdue Pharma Profile
Table Purdue Pharma Overview List
4.8.2 Purdue Pharma Products & Services
4.8.3 Purdue Pharma Business Operation Conditions
Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 S.L.A. Pharma AG (Company Profile, Sales Data etc.)
4.9.1 S.L.A. Pharma AG Profile
Table S.L.A. Pharma AG Overview List
4.9.2 S.L.A. Pharma AG Products & Services
4.9.3 S.L.A. Pharma AG Business Operation Conditions
Table Business Operation of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Mundipharma International Limited (Company Profile, Sales Data etc.)
4.10.1 Mundipharma International Limited Profile
Table Mundipharma International Limited Overview List
4.10.2 Mundipharma International Limited Products & Services
4.10.3 Mundipharma International Limited Business Operation Conditions
Table Business Operation of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Ono Pharmaceutical Co., Ltd (Company Profile, Sales Data etc.)
4.11.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
4.11.2 Ono Pharmaceutical Co., Ltd Products & Services
4.11.3 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Takeda Pharmaceutical Company Limited (Company Profile, Sales Data etc.)
4.12.1 Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Overview List
4.12.2 Takeda Pharmaceutical Company Limited Products & Services
4.12.3 Takeda Pharmaceutical Company Limited Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Cost, Gross Margin)
4.13 Theravance Biopharma Inc (Company Profile, Sales Data etc.)
4.13.1 Theravance Biopharma Inc Profile
Table Theravance Biopharma Inc Overview List
4.13.2 Theravance Biopharma Inc Products & Services
4.13.3 Theravance Biopharma Inc Business Operation Conditions
Table Business Operation of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Valeant Pharmaceuticals International (Company Profile, Sales Data etc.)
4.14.1 Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Overview List
4.14.2 Valeant Pharmaceuticals International Products & Services
4.14.3 Valeant Pharmaceuticals International Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Cost, Gross Margin)
4.15 Cosmo Pharmaceuticals SA (Company Profile, Sales Data etc.)
4.15.1 Cosmo Pharmaceuticals SA Profile
Table Cosmo Pharmaceuticals SA Overview List
4.15.2 Cosmo Pharmaceuticals SA Products & Services
4.15.3 Cosmo Pharmaceuticals SA Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals SA (Sales Revenue, Cost, Gross Margin)
4.16 Daewoong Pharmaceutical (Company Profile, Sales Data etc.)
4.16.1 Daewoong Pharmaceutical Profile
Table Daewoong Pharmaceutical Overview List
4.16.2 Daewoong Pharmaceutical Products & Services
4.16.3 Daewoong Pharmaceutical Business Operation Conditions
Table Business Operation of Daewoong Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.17 C.B. Fleet Company (Company Profile, Sales Data etc.)
4.17.1 C.B. Fleet Company Profile
Table C.B. Fleet Company Overview List
4.17.2 C.B. Fleet Company Products & Services
4.17.3 C.B. Fleet Company Business Operation Conditions
Table Business Operation of C.B. Fleet Company (Sales Revenue, Cost, Gross Margin)
4.18 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
4.18.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
4.18.2 Sucampo Pharmaceuticals Products & Services
4.18.3 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Opioid Induced Constipation Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Opioid Induced Constipation Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Opioid Induced Constipation Drugs Sales Revenue Share in 2020, by Company, in USD Million
5.2 Regional Market by Company
Figure North America Opioid Induced Constipation Drugs Market Concentration, in 2020
Figure Europe Opioid Induced Constipation Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Opioid Induced Constipation Drugs MMarket Concentration, in 2020
Figure South America Opioid Induced Constipation Drugs Market Concentration, in 2020
Figure Middle East & Africa Opioid Induced Constipation Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
Figure Opioid Induced Constipation Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
6.1.2 Demand in Retail Pharmacies
Figure Opioid Induced Constipation Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
6.1.3 Demand in Online Pharmacies
Figure Opioid Induced Constipation Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Opioid Induced Constipation Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Opioid Induced Constipation Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Opioid Induced Constipation Drugs Market Share in 2026, by Application, in USD Million
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Opioid Induced Constipation Drugs Production 2016-2020, by Region, in USD Million
7.2 Regional Market
Table Global Opioid Induced Constipation Drugs Market 2016-2020, by Region, in USD Million
Table Global Opioid Induced Constipation Drugs Market Share 2016-2020, by Region, in USD Million
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.4 South America
7.3.4.1 Overview
Figure South America Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.4 Regional Import & Export
7.5 Regional Forecast
Table Opioid Induced Constipation Drugs Market Forecast 2021-2026, by Region, in USD Million
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Opioid Induced Constipation Drugs
2. Table Application Segment of Opioid Induced Constipation Drugs
3. Table Global Opioid Induced Constipation Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Methyl Naltrexone Bromide
5. Table Major Company List of Naldemedine
6. Table Major Company List of Alvimopan
7. Table Major Company List of Others
8. Table Global Opioid Induced Constipation Drugs Market 2016-2020, by Type, in USD Million
9. Table Global Opioid Induced Constipation Drugs Market Forecast 2021-2026, by Type, in USD Million
10. Table Ironwood Pharmaceuticals Inc Overview List
11. Table Business Operation of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Daiichi Sankyo Co Ltd Overview List
13. Table Business Operation of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Pfizer Overview List
15. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Progenics Pharmaceuticals Inc Overview List
17. Table Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Shionogi & Co., Ltd Overview List
19. Table Business Operation of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Allergan Plc Overview List
21. Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Nektar Therapeutics Overview List
23. Table Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Purdue Pharma Overview List
25. Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table S.L.A. Pharma AG Overview List
27. Table Business Operation of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Mundipharma International Limited Overview List
29. Table Business Operation of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Ono Pharmaceutical Co., Ltd Overview List
31. Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Takeda Pharmaceutical Company Limited Overview List
33. Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Cost, Gross Margin)
34. Table Theravance Biopharma Inc Overview List
35. Table Business Operation of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
36. Table Valeant Pharmaceuticals International Overview List
37. Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Cost, Gross Margin)
38. Table Cosmo Pharmaceuticals SA Overview List
39. Table Business Operation of Cosmo Pharmaceuticals SA (Sales Revenue, Cost, Gross Margin)
40. Table Daewoong Pharmaceutical Overview List
41. Table Business Operation of Daewoong Pharmaceutical (Sales Revenue, Cost, Gross Margin)
42. Table C.B. Fleet Company Overview List
43. Table Business Operation of C.B. Fleet Company (Sales Revenue, Cost, Gross Margin)
44. Table Sucampo Pharmaceuticals Overview List
45. Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
46. Table Global Opioid Induced Constipation Drugs Sales Revenue 2016-2020, by Company, in USD Million
47. Table Global Opioid Induced Constipation Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
48. Table Regional Demand Comparison List
49. Table Major Application in Different Regions
50. Table Opioid Induced Constipation Drugs Demand Forecast 2021-2026, by Application, in USD Million
51. Table Opioid Induced Constipation Drugs Production 2016-2020, by Region, in USD Million
52. Table Global Opioid Induced Constipation Drugs Market 2016-2020, by Region, in USD Million
53. Table Global Opioid Induced Constipation Drugs Market Share 2016-2020, by Region, in USD Million
54. Table North America Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
55. Table Europe Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
57. Table South America Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
59. Table Opioid Induced Constipation Drugs Market Forecast 2021-2026, by Region, in USD Million
60. Table Price Factors List
List of Figure
1. Figure Opioid Induced Constipation Drugs Industry Chain Structure
2. Figure Global Opioid Induced Constipation Drugs Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Opioid Induced Constipation Drugs Sales Revenue Share in 2020, by Company, in USD Million
4. Figure North America Opioid Induced Constipation Drugs Market Concentration, in 2020
5. Figure Europe Opioid Induced Constipation Drugs Market Market Concentration, in 2020
6. Figure Asia-Pacific Opioid Induced Constipation Drugs MMarket Concentration, in 2020
7. Figure South America Opioid Induced Constipation Drugs Market Concentration, in 2020
8. Figure Middle East & Africa Opioid Induced Constipation Drugs Market Concentration, in 2020
9. Figure Opioid Induced Constipation Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
10. Figure Opioid Induced Constipation Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
11. Figure Opioid Induced Constipation Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
12. Figure Opioid Induced Constipation Drugs Market Growth 2021-2026, by Application, in USD Million
13. Figure Opioid Induced Constipation Drugs Market Share in 2026, by Application, in USD Million
14. Figure North America Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
15. Figure Europe Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
16. Figure Asia-Pacific Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
17. Figure South America Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
18. Figure Middle East & Africa Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
19. Figure Marketing Channels Overview
Request Sample 
Request Discount 
Inquire Before Buy
